These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23824014)

  • 1. Potentials and limitations of nonclinical safety assessment for predicting clinical adverse drug reactions: correlation analysis of 142 approved drugs in Japan.
    Tamaki C; Nagayama T; Hashiba M; Fujiyoshi M; Hizue M; Kodaira H; Nishida M; Suzuki K; Takashima Y; Ogino Y; Yasugi D; Yoneta Y; Hisada S; Ohkura T; Nakamura K
    J Toxicol Sci; 2013; 38(4):581-98. PubMed ID: 23824014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety Profile Based on Concordance of Nonclinical Toxicity and Clinical Adverse Drug Reactions for Blood Cancer Drugs Approved in Japan.
    Kubota S; Saito K; Ono S; Kodama Y
    Drugs R D; 2017 Mar; 17(1):133-143. PubMed ID: 27995532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Drug Reactions for Medicines Newly Approved in Japan from 1999 to 2013: Hypertension and Hypotension.
    Nagayama T; Nishida M; Hizue M; Ogino Y; Fujiyoshi M
    Basic Clin Pharmacol Toxicol; 2016 Apr; 118(4):306-12. PubMed ID: 26407539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicologic Pathology Forum: Current Status on the Use of Animal Models of Human Disease in the Pharmaceutical Industry in Japan in Nonclinical Safety Assessment-Opinion Paper.
    Tomohiro M; Okabe T; Kimura Y; Kinoshita K; Maeda M; Mitobe Y; Motoyama K; Yonezawa R; Sasaki S; Fujiwara M; Watanabe K
    Toxicol Pathol; 2019 Feb; 47(2):108-120. PubMed ID: 30636562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety-Related Regulatory Actions and Risk Factors for Anticancer Drugs in Japan.
    Nakayama H; Matsumaru N; Tsukamoto K
    Pharmaceut Med; 2019 Feb; 33(1):45-52. PubMed ID: 31933266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public awareness of adverse drug reaction medical safety.
    AlHusaini FA; Al Mubarak MMS
    Int J Health Care Qual Assur; 2018 Jul; 31(6):520-530. PubMed ID: 29954261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis and enhancement of risk management for ethnic differences in antineoplastic drugs in Japan.
    Uzu S; Sato J; Wakao R; Nonaka T
    BMC Health Serv Res; 2022 Oct; 22(1):1292. PubMed ID: 36289504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reaction profile of microtubule-damaging antineoplastic drugs: A focused pharmacovigilance study in India.
    Manohar HD; Adiga S; Thomas J; Sharma A
    Indian J Pharmacol; 2016; 48(5):509-514. PubMed ID: 27721535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting toxicities in humans by nonclinical safety testing: an update with particular reference to anticancer compounds.
    Ahuja V; Bokan S; Sharma S
    Drug Discov Today; 2017 Jan; 22(1):127-132. PubMed ID: 27644594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug reactions for medicine newly approved in Japan from 1999 to 2013: Syncope/loss of consciousness and seizures/convulsions.
    Nagayama T
    Regul Toxicol Pharmacol; 2015 Aug; 72(3):572-7. PubMed ID: 26056066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions in neonates: a prospective study.
    Belén Rivas A; Arruza L; Pacheco E; Portoles A; Diz J; Vargas E
    Arch Dis Child; 2016 Apr; 101(4):371-6. PubMed ID: 26819267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA.
    Wu L; Ingle T; Liu Z; Zhao-Wong A; Harris S; Thakkar S; Zhou G; Yang J; Xu J; Mehta D; Ge W; Tong W; Fang H
    BMC Bioinformatics; 2019 Mar; 20(Suppl 2):97. PubMed ID: 30871458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ophthalmic adverse drug reactions to systemic drugs: a systematic review.
    Miguel A; Henriques F; Azevedo LF; Pereira AC
    Pharmacoepidemiol Drug Saf; 2014 Mar; 23(3):221-33. PubMed ID: 24464938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting adverse drug reactions using publicly available PubChem BioAssay data.
    Pouliot Y; Chiang AP; Butte AJ
    Clin Pharmacol Ther; 2011 Jul; 90(1):90-9. PubMed ID: 21613989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reactions experience in a teaching hospital in Jordan.
    Alsbou M; Alzubiedi S; Alzobi H; Samhadanah NA; Alsaraireh Y; Alrawashdeh O; Aqel A; Al-Salem K
    Int J Clin Pharm; 2015 Dec; 37(6):1188-93. PubMed ID: 26286340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
    Neubert A; Dormann H; Weiss J; Egger T; Criegee-Rieck M; Rascher W; Brune K; Hinz B
    Drug Saf; 2004; 27(13):1059-67. PubMed ID: 15471510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.